Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

bioMérieux S.A.. (4/20/16). "Press Release: bioMérieux – First-quarter 2016 Business Review. Solid Growth in Sales, up 11.5% at Constant Exchange Rates and Scope of Consolidation".

Organisations Organisation bioMérieux S.A. (Euronext: BIM)
  Group Mérieux (Group)
  Organisation 2 bioTheranostics Inc.
Product Product  FilmArray® PCR test (product series)
Person Person Mérieux, Alexandre (bioMérieux 201404– CEO before VP Industrial Microbiology)
     


> €489 million in sales

> Up 9.1% as reported

> Americas (up 22.5%) confirms its role as a key growth driver for the Group

> Clinical microbiology: up 6.7%, driven primarily by successful sales of the VITEK® and BacT/ALERT® lines

> FilmArray® Torch high-throughput system CE marked and FDA cleared with all four existing FilmArray® panels


Alexandre Mérieux, Chief Executive Officer, said: "Supported by strong momentum in the Americas and a good start in the Asia-Pacific region, we achieved organic growth of 11.5% in the first three months of the year. Backed by our solid first-quarter 2016 performance, we are continuing our drive to enhance operating efficiency in line with our strategic roadmap and our full-year objectives."

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2016.


Sales

Consolidated sales rose to €489 million in the first three months of 2016 from €448 million in the year-earlier period. This represents growth of 9.1% as reported and includes a negative currency impact of around €7 million as well as the previously announced deconsolidation of bioTheranostics as of January 1, 2016. Organic growth (at constant exchange rates and scope of consolidation) represented 11.5% year-on-year, led by strong FilmArray® sales (for around 400 basis points), despite a weaker flu season that also began later than in the same period of 2015.


Download
- See more at: http://www.biomerieux.com/en/biomerieux-first-quarter-2016-business-review#sthash.LqeIb1Gw.dpuf

   
Record changed: 2016-06-01

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Mérieux (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px